Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile

Kamat, 2016, Bladder cancer, Lancet, 388, 2796, 10.1016/S0140-6736(16)30512-8 Gontero, 2010, The role of bacillus Calmette-Guerin in the treatment of non–muscle-invasive bladder cancer, Eur Urol, 57, 410, 10.1016/j.eururo.2009.11.023 Babjuk, 2017, EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016, Eur Urol, 71, 447, 10.1016/j.eururo.2016.05.041 Mostafid, 2015, Therapeutic options in high-risk non–muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Guerin, Eur Urol, 67, 359, 10.1016/j.eururo.2014.11.031 Germanier, 1975, Isolation and characterization of galE mutant Ty 21a of Salmonella typhi. A candidate strain for a live, oral typhoid vaccine, J Infect Dis, 131, 553, 10.1093/infdis/131.5.553 Guzman, 2006, Vaccines against typhoid fever, Vaccine, 24, 3804, 10.1016/j.vaccine.2005.07.111 Domingos-Pereira, 2017, Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer, Oncoimmunology, 6, e1265720, 10.1080/2162402X.2016.1265720 Domingos-Pereira, 2019, Intravesical Ty21a vaccine promotes dendritic cells and T cell-mediated tumor regression in the MB49 bladder cancer model, Cancer Immunol Res, 7, 621, 10.1158/2326-6066.CIR-18-0671 Summerhayes, 1979, Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro, J Natl Cancer Inst, 62, 1017 Orihuela, 1987, Toxicity of intravesical BCG and its management in patients with superficial bladder tumors, Cancer, 60, 326, 10.1002/1097-0142(19870801)60:3<326::AID-CNCR2820600309>3.0.CO;2-5 Berry, 1996, Local toxicity patterns associated with intravesical bacillus Calmette-Guerin: a Southwest Oncology Group study, Int J Urol, 3, 98, 10.1111/j.1442-2042.1996.tb00490.x van der Meijden, 2003, EORTC Genito-Urinary Tract Cancer Group. Maintenance bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial, Eur Urol, 44, 429, 10.1016/S0302-2838(03)00357-9 Koch, 2021, Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them, Urology, 149, 11, 10.1016/j.urology.2020.10.039 Gilman, 1977, Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine, J Infect Dis, 136, 717, 10.1093/infdis/136.6.717 Ipe, 2016, The basics of bacteriuria: strategies of microbes for persistence in urine, Front Cell Infect Microbiol, 6, 14, 10.3389/fcimb.2016.00014 Mathai, 1995, Significance of Salmonella typhi bacteriuria, J Clin Microbiol, 33, 1791, 10.1128/jcm.33.7.1791-1792.1995 Durek, 2001, The fate of bacillus Calmette-Guerin after intravesical instillation, J Urol, 165, 1765, 10.1016/S0022-5347(05)66410-5